Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease (vol 2016, 9890141, 2016)

被引：0
|
作者：
Phillips-Farfan, Bryan [1 ]
Carvajal, Karla [1 ]
Medina-Torres, Edgar Alejandro [2 ]
Espinosa-Padilla, Sara Elva [2 ]
Fabrias, Gemma [3 ]
Camacho, Luz [1 ]
机构：
[1] Inst Nacl Pediat, Lab Nutr Expt, Ciudad De Mexico 04530, Mexico
[2] Inst Nacl Pediat, Unidad Invest Inmunodeficiencias, Ciudad De Mexico 04530, Mexico
[3] CSIC, IQAC, Inst Adv Chem Catalonia, Dept Biomed Chem,Res Unit Bioact Mol, ES-08034 Barcelona, Spain
来源：
MEDIATORS OF INFLAMMATION | 2016年 / 2016卷
关键词：
D O I：
10.1155/2016/7267956
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease
    Kumar, Kathryn Prame
    Ooi, Joshua D.
    Goldberg, Rimma
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [32] Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease
    Buela, Kristine-Ann G.
    Omenetti, Sara
    Pizarro, Theresa T.
    CURRENT OPINION IN GASTROENTEROLOGY, 2015, 31 (06) : 449 - 455
  • [33] How do immune and mesenchymal cells influence the intestinal epithelial cell compartment in inflammatory bowel disease? Let's crosstalk about it!
    Rees, William D.
    Sly, Laura M.
    Steiner, Theodore S.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2020, 108 (01) : 309 - 321
  • [34] INPATIENT CORRELATION BETWEEN INFLAMMATORY BOWEL DISEASE FLARES AND RHEUMATOID ARTHRITIS. NATIONWIDE INPATIENT SAMPLE 2016-2020
    Alqaisieh, Mohammad
    El Sharu, Husam
    Chaudhary, Ammad J.
    Al-Thunaibat, Ahmad
    Ali, Hassam
    GASTROENTEROLOGY, 2024, 166 (05) : S1156 - S1156
  • [35] Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial (vol 22, pg 638, 2016)
    deBruyn, J.
    Fonesca, K.
    Ghosh, S.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (09) : 2310 - 2310
  • [36] Research progress on the relationship between Paneth cells-susceptibility genes, intestinal microecology and inflammatory bowel disease
    Zhou, Qi-Ming
    Zheng, Lie
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (34) : 8111 - 8125
  • [37] Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease
    Friedrich, M.
    Diegelmann, J.
    Schauber, J.
    Auernhammer, C. J.
    Brand, S.
    MUCOSAL IMMUNOLOGY, 2015, 8 (04) : 943 - 958
  • [38] Trend and Geographic Variation in Incidence and Prevalence of Inflammatory Bowel Disease in Regions Across China: A Nationwide Employee Study Between 2013 and 2016
    Yang, Hong
    Zhou, Runing
    Bai, Xiaoyin
    Guo, Mingyue
    Ruan, Gechong
    Wang, Li
    Qian, Jiaming
    FRONTIERS IN MEDICINE, 2022, 9
  • [39] Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease (vol 48, pg 360, 2016)
    Armuzzi, Alessandro
    Gionchetti, Paolo
    Daperno, Marco
    Danese, Silvio
    Orlando, Ambrogio
    Scribano, Maria Lia
    Vecchi, Maurizio
    Rizzello, Fernando
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (09) : 1104 - 1104
  • [40] Molecular Mechanisms of Skatole-Induced Inflammatory Responses in Intestinal Epithelial Caco-2 Cells: Implications for Colorectal Cancer and Inflammatory Bowel Disease
    Ishii, Katsunori
    Naito, Kazuma
    Tanaka, Dai
    Koto, Yoshihito
    Kurata, Koichi
    Shimizu, Hidehisa
    CELLS, 2024, 13 (20)
12345